中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
36期
108-109
,共2页
雷贝拉唑%十二指肠溃疡%临床疗效
雷貝拉唑%十二指腸潰瘍%臨床療效
뢰패랍서%십이지장궤양%림상료효
Rabeprazole%Duodenal ulcer%Clinical curative effect
目的：探讨雷贝拉唑治疗十二指肠溃疡的临床效果。方法：将2012年2月-2013年4月本院收治的130例十二指肠溃疡患者根据治疗方法分为观察组和对照组，每组各65例，两组均给予常规治疗，观察组加用雷贝拉唑，对照组加用法莫替丁，比较两组患者的症状积分和临床疗效。结果：观察组总有效率为96.9%，明显优于对照组的83.1%，两组比较差异有统计学意义（P<0.05）；观察组治疗后1、4周的症状积分均优于对照组，两组比较差异有统计学意义（P<0.05）。结论：雷贝拉唑治疗十二指肠溃疡的临床疗效明显优于法莫替丁。
目的：探討雷貝拉唑治療十二指腸潰瘍的臨床效果。方法：將2012年2月-2013年4月本院收治的130例十二指腸潰瘍患者根據治療方法分為觀察組和對照組，每組各65例，兩組均給予常規治療，觀察組加用雷貝拉唑，對照組加用法莫替丁，比較兩組患者的癥狀積分和臨床療效。結果：觀察組總有效率為96.9%，明顯優于對照組的83.1%，兩組比較差異有統計學意義（P<0.05）；觀察組治療後1、4週的癥狀積分均優于對照組，兩組比較差異有統計學意義（P<0.05）。結論：雷貝拉唑治療十二指腸潰瘍的臨床療效明顯優于法莫替丁。
목적：탐토뢰패랍서치료십이지장궤양적림상효과。방법：장2012년2월-2013년4월본원수치적130례십이지장궤양환자근거치료방법분위관찰조화대조조，매조각65례，량조균급여상규치료，관찰조가용뢰패랍서，대조조가용법막체정，비교량조환자적증상적분화림상료효。결과：관찰조총유효솔위96.9%，명현우우대조조적83.1%，량조비교차이유통계학의의（P<0.05）；관찰조치료후1、4주적증상적분균우우대조조，량조비교차이유통계학의의（P<0.05）。결론：뢰패랍서치료십이지장궤양적림상료효명현우우법막체정。
Objective:To explore the clinical effect of rabeprazole treatment of duodenal ulcer. Method:130 patients with duodenal ulcer were treated in our hospital from February 2012 to April 2013,they were divided into observation group and control group according to treatment method,65 cases in each group,the patients in the two groups were given conventional treatment,the observation group added with rabeprazole,the control group added with famotidine,the symptoms integral and clinical curative effect between the two groups were compared. Result:The total effective rate of the observation group was 96.9%and better than the control group of 83.1%,the difference was statistically significant between the two groups(P<0.05). The symptoms of integral in the observation group 1,4 weeks after treatment were better than that of control group,the difference were statistically significant between the two groups(P<0.05). Conclusion:The clinical curative effect of rabeprazole treatment of duodenal ulcer is significantly better than that of famotidine.
